Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Argus Health
Moodys
QuintilesIMS
Queensland Health
Fuji
Colorcon
Express Scripts
Citi

Generated: February 25, 2018

DrugPatentWatch Database Preview

Meclofenamate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for meclofenamate sodium and what is the scope of meclofenamate sodium patent protection?

Meclofenamate sodium
is the generic ingredient in three branded drugs marketed by Quantum Pharmics, Am Therap, Barr, Fosun Pharma, Mylan, Par Pharm, Usl Pharma, Vitarine, Watson Labs, Watson Labs Teva, and Parke Davis, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for meclofenamate sodium. One supplier is listed for this compound.

US Patents and Regulatory Information for meclofenamate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 072077-001 Mar 10, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fosun Pharma MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 072263-001 Nov 29, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis MECLOMEN meclofenamate sodium CAPSULE;ORAL 018006-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071468-001 Apr 15, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis MECLOMEN meclofenamate sodium CAPSULE;ORAL 018006-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vitarine MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071684-001 Jun 15, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 072078-001 Mar 10, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Usl Pharma MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071007-001 Mar 25, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 072809-001 Mar 20, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Am Therap MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071362-001 Feb 10, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Merck
Express Scripts
Dow
Boehringer Ingelheim
Healthtrust
Federal Trade Commission
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot